Finance

Beta
Lists
RGEN:NASDAQ
Repligen Corp
145,16 $
+4,88%
(+6,76) 1D
25 հնս, 14:15:54 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RGEN...
Open
143,00 $
High
149,05 $
Low
140,44 $
Mkt. cap
8,19 մլրդ
Avg. vol.
1,17 մլն
Volume
1,03 մլն
P/E ratio
159,30
52-wk high
175,57 $
52-wk low
100,99 $
EPS
0,91 $
Beta
1,09
Shares outstanding
56,41 մլն
No. of employees
2 հզր
Open
143,00 $
High
149,05 $
Low
140,44 $
Mkt. cap
8,19 մլրդ
Avg. vol.
1,17 մլն
Volume
1,03 մլն
P/E ratio
159,30
52-wk high
175,57 $
52-wk low
100,99 $
EPS
0,91 $
Beta
1,09
Shares outstanding
56,41 մլն
No. of employees
2 հզր
News stories
From sources across the web
Stock Titan
Stock Titan
·
21 րոպե առաջ
[144] REPLIGEN CORP SEC Filing
Insider Monkey
Insider Monkey
·
1 օր առաջ
Repligen Corporation (RGEN) Dropped Following the Earnings Release
Profile
Repligen Corporation is an American life sciences company that develops and manufactures products used in biological drug manufacturing. The company is headquartered in Waltham, Massachusetts, and is listed on the Nasdaq under the symbol RGEN. Wikipedia
About Repligen Corp
CEOTony J. Hunt
Employees2 հզր
Founded1981
HeadquartersՈւոլթեմ, Մասսաչուսեթս, Միացյալ Նահանգներ
Sector-
Websiterepligen.com
Analyst ratings
Based on 14 analysts giving stock ratings to RGEN in the past 3 months
Strong buy
Buy
11
Hold
3
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for RGEN in the last 3 months.
Highest
Current 145,16 $
207,00 $ (+42,61%)
Average
161,27 $ (+11,10%)
Lowest
140,00 $ (-3,55%)
Analyst
Recommendation
Action
Price target
Projected
Date
Matt Hewitt
Craig-Hallum
Buy
Maintained
-
-
06/24/2026
Luke Sergott
Barclays
Buy
Maintained
160,00 $
+10,2%
06/24/2026
Yessica Sanchez Gudino
HSBC
Buy
Maintained
150,00 $
+3,3%
06/03/2026
Unknown Analyst
HSBC
Buy
Maintained
150,00 $
+3,3%
06/03/2026
Michael Polark
Wolfe Research
Buy
Initiated
145,00 $
-0,1%
06/01/2026
Matt Larew
William Blair
Buy
Maintained
-
-
05/14/2026
Dan Leonard
RBC Capital
Buy
Initiated
160,00 $
+10,2%
05/14/2026
Unknown Analyst
RBC Capital
Buy
Initiated
160,00 $
+10,2%
05/14/2026
Unknown Analyst
Guggenheim
Hold
Reiterated
-
-
05/07/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
207,00 $
+42,6%
05/06/2026
Casey Woodring
J.P. Morgan
Buy
Maintained
165,00 $
+13,7%
05/06/2026
Kyle Mikson CFA
Canaccord Genuity
Hold
Maintained
145,00 $
-0,1%
05/06/2026
Matthew Stanton, CFA
Jefferies
Hold
Maintained
142,00 $
-2,2%
05/05/2026
Brendan Smith
TD Cowen
Buy
Maintained
200,00 $
+37,8%
05/05/2026
Natalya Davies
Rothschild & Co Redburn
Buy
Initiated
160,00 $
+10,2%
04/17/2026
Daniel Markowitz CFA
Evercore ISI
Buy
Reiterated
140,00 $
-3,6%
04/06/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
208,00 $
+43,3%
03/23/2026
Subbu Nambi
Guggenheim
Hold
Maintained
-
-
02/24/2026
Brandon Couillard
Wells Fargo
Buy
Maintained
180,00 $
+24%
02/25/2026
Paul Knight
KeyBanc
Buy
Maintained
220,00 $
+51,6%
02/25/2026
Last report
05 մյս, 2026 թ.
Fiscal period
Q1 2026
EPS / Est. (USD)
0,48 $ / 0,39 $
+22,87%beat
Revenue / Est. (USD)
194,26 մլն / 192,35 մլն
+0,99%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
Revenue
182,37 մլն
188,80 մլն
197,91 մլն
194,26 մլն
Cost of goods sold
89,37 մլն
88,29 մլն
94,08 մլն
85,97 մլն
Cost of revenue
89,37 մլն
88,29 մլն
94,08 մլն
85,97 մլն
Research and development expenses
13,97 մլն
14,18 մլն
13,12 մլն
14,46 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
69,41 մլն
73,66 մլն
74,36 մլն
76,54 մլն
Operating expense
83,38 մլն
87,84 մլն
87,48 մլն
90,99 մլն
Total operating expenses
172,75 մլն
176,13 մլն
181,56 մլն
176,96 մլն
Operating income
9,62 մլն
12,68 մլն
16,35 մլն
17,29 մլն
Other non operating income
3,50 մլն
-446,00 հզր
-11,48 մլն
-750,00 հզր
EBT including unusual items
18,22 մլն
17,11 մլն
19,11 մլն
1,77 մլն
EBT excluding unusual items
13,94 մլն
12,96 մլն
17,59 մլն
16,88 մլն
Income tax expense
3,35 մլն
2,20 մլն
5,83 մլն
-6,56 մլն
Effective tax rate
18,39%
12,86%
30,48%
-370,26%
Other operating expenses
-
-
-
-
Net income
14,87 մլն
14,91 մլն
13,29 մլն
8,33 մլն
Net profit margin
8,15%
7,90%
6,71%
4,29%
Earnings per share
0,37
0,46
0,49
0,48
Interest and investment income
6,58 մլն
6,92 մլն
6,75 մլն
6,34 մլն
Interest expense
-5,77 մլն
-5,83 մլն
-5,91 մլն
-6,00 մլն
Net interest expenses
817,00 հզր
1,09 մլն
842,00 հզր
345,00 հզր
Depreciation and amortization charges
-
-
-
-
EBITDA
29,70 մլն
32,69 մլն
36,30 մլն
37,05 մլն
Gain or loss from assets sale
2,16 մլն
-3,38 մլն
-
13,76 մլն
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of RGEN
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer